ទំព័រដើម › ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ › ប៉ែនស៊ីលវ៉ានី › Philadelphia
ការសាកល្បងគ្លីនិកសម្រាប់ ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ នៅក្នុង Philadelphia, PA
ការសិក្សាចំនួន 34 សម្រាប់ ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ Philadelphia (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Thomas Jefferson University Hospital, Philadelphia
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
កំពុងជ្រើសរើសដំណាក់កាល 1
- Children's Hospital of Philadelphia, Philadelphia
Assessment of Geriatric Evaluations Impact on New AML Guidance
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · ឆ្ងាយ 22 ម៉ាយ
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Children's Hospital of Philadelphia, Philadelphia
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Thomas Jefferson University Hospital, Philadelphia
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
កំពុងជ្រើសរើសដំណាក់កាល 3
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · ឆ្ងាយ 25 ម៉ាយ
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pennsylvania, Philadelphia
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
កំពុងជ្រើសរើសដំណាក់កាល 1
- UPENN Perelman Center for Advanced Medicine, Philadelphia
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
កំពុងជ្រើសរើសដំណាក់កាល 3
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · ឆ្ងាយ 25 ម៉ាយ
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · ឆ្ងាយ 25 ម៉ាយ
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Children's Hospital of Philadelphia, Philadelphia
- Nemours Alfred I. Dupont Hospital for Children, Wilmington · ឆ្ងាយ 25 ម៉ាយ
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
កំពុងជ្រើសរើសដំណាក់កាល 3
- University of Pennsylvania, Philadelphia
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- University of Pennsylvania, Philadelphia
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
កំពុងជ្រើសរើសដំណាក់កាល 1
- Children's Hospital of Philadelphia, Philadelphia
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
កំពុងជ្រើសរើសដំណាក់កាល 2
- Penn Medicine Abramson Cancer Center, Philadelphia
CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of Pennsylvania, Philadelphia
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
កំពុងជ្រើសរើស
- Children's Hospital of Philadelphia, Philadelphia
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
កំពុងជ្រើសរើសដំណាក់កាល 1
- Children's Hospital of Philadelphia, Philadelphia
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Children's Hospital of Philadelphia, Philadelphia
- Nemours - Alfred I. duPont Hospital for Children, Brandywine · ឆ្ងាយ 21 ម៉ាយ
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of Pennsylvania, Philadelphia
Massage Impact on Sleep in Pediatric Oncology
កំពុងជ្រើសរើស
- Children's Hospital of Philadelphia, Philadelphia
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Phase IB/II of CPX-351 for Relapse Prevention in AML
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pennsylvania, Philadelphia
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
កំពុងជ្រើសរើសដំណាក់កាល 1
- Thomas Jefferson University Hospital, Philadelphia
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
កំពុងជ្រើសរើសដំណាក់កាល 1
- Hospital of the University of Pennsylvania, Philadelphia
Tazemetostat and Palbociclib With CPX-351for R/R AML
កំពុងជ្រើសរើសដំណាក់កាល 1
- Thomas Jefferson University Hospital, Philadelphia
Home Blood Transfusions
កំពុងជ្រើសរើស
- Thomas Jefferson University Hospital, Philadelphia
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
កំពុងជ្រើសរើសស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- University of Pennsylvania, Philadelphia
ការសាកល្បងសម្រាប់ ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ នៅក្នុងទីក្រុងផ្សេងទៀត
- Houston, TXការសិក្សា 85
- New York City, NYការសិក្សា 51
- Boston, MAការសិក្សា 44
- Seattle, WAការសិក្សា 41
- Baldwin Park, CAការសិក្សា 40
- Columbus, OHការសិក្សា 35
- Durham, NCការសិក្សា 33
- Atlanta, GAការសិក្សា 31
- Tampa, FLការសិក្សា 29
- Chicago, ILការសិក្សា 26
- Portland, ORការសិក្សា 25
- Washington, DCការសិក្សា 24
ការសិក្សាផ្សេងទៀតនៅក្នុង Philadelphia
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 59
- មហារីកទ្រូងការសិក្សា 56
- Non-Small Cell Lung Cancerការសិក្សា 51
- មហារីកដែលរីករាលដាលការសិក្សា 46
- មហារីកតូចការសិក្សា 44
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 44
- មហារីកស៊ុតការសិក្សា 44
- មហារីកសួតការសិក្សា 36
- បេះដូងខ្សោយការសិក្សា 31
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 28
- ភាពសោកសៅការសិក្សា 26
- មហារីកតំបក់ការសិក្សា 26
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។